Navigation Links
Penn researchers unlock molecular origin of blood stem cells
Date:1/9/2009

PHILADELPHIA A research team led by Nancy Speck, PhD, Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine, has identified the location and developmental timeline in which a majority of bone marrow stem cells form in the mouse embryo. The findings, appearing online this week in the journal Nature, highlight critical steps in the origin of hematopoietic (or blood) stem cells (HSCs), says senior author Speck, who is also an Investigator with the Abramson Family Cancer Research Institute at Penn.

Because HSCs, found in the bone marrow of adult mammals, generate all of the blood cell types of the body, unlocking the secrets of their origin may help researchers to better manipulate embryonic stem cells to generate new blood cells for therapy.

"The ultimate goal for stem cell therapies is to take embryonic stem cells and push them down a particular lineage to replace diseased or dead cells in human adults or children," says Speck. For instance, in theory embryonic stem cells could be tweaked in a lab to provide a patient with bone marrow failure a fresh supply of compatible HSCs.

To date, however, Speck says scientists have been unable to coax embryonic stem cells to become HSCs without significant genetic manipulations that are too risky for clinical therapies. First things first, Speck says: "You have to understand what's happening in the embryo."

Previous studies hinted that HSCs originated from a small population of cells lining the blood vessels, called endothelial cells. But, it was unclear how endothelial cells transitioned to blood stem cells during early development.

Before joining Penn in September 2008, Speck, then at Dartmouth Medical School, led a team that confirmed that HSCs in bone marrow were originating from the endothelial cells and determined whether the activity of a protein called Runx1, which is known to be critical in the formation of blood cell
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine
2. McGill researchers discover gene that increases susceptibility to Crohns disease
3. Researchers Gain Insights Into Aging in Mice
4. Researchers discover target that could ease spinal muscular atrophy symptoms
5. Health-monitoring technology helps seniors live at home longer, MU researchers find
6. Old gastrointestinal drug slows aging, McGill researchers say
7. NC State researchers find new bartonella species that infects humans
8. Researchers Report Progress in Fight Against Fat
9. Mayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding
10. Burnham researchers illuminate mechanisms that regulate DNA damage control and replication
11. Relocation plan of metastatic cancer cells uncovered by Stanford researchers

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penn researchers unlock molecular origin of blood stem cells
Penn researchers unlock molecular origin of blood stem cells
(Date:11/25/2009)...ttleImprovementShownforthe4thStraightYear ,, ...LungCancerAlliance-Georgia(LCA-GA)issuedthe 4thAnn...tofprogressbeingmadeagainstthislethaldiseaseinthes...(LCA),theonlynationalorganizationdedicatedexclusiv...ratriskforlungcancer. ,, (Logo: http://www.news...
(Date:11/25/2009)...d to treat colorectal cancer also can reverse a ra...-line therapy for the disease, researchers at Vand... , Mntrier,s disease causes thickening of the sto...iting, as well as anemia and swelling in the feet ...creased risk for gastric cancer. Previously, the o...
(Date:11/25/2009)...ks placed under the skin kill tumor cells, study f...ews) -- A cancer vaccine delivered in a fingernail...a new study reports. , The method uses polymer ...d with tumor-specific antigens and implanted under... tumors. The Harvard University scientists who dev...
(Date:11/25/2009)... Nationwide Imaging Services, known a...ns for diagnostic imaging equipment, now offering ...ng financing options, service and installation wit...edical Technologies of California) , ... Nationwide Imaging Services is proud to announce ...
(Date:11/25/2009)... BioSpace.com, the premier resource f...the third edition of the BioForest™ Hotbed C...nglewood, CO (Vocus) November 25, 2009 -- BioSpace...s and information, unveiled the third edition of t... , , , ,This regional campaign is a promotional e...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ng a victim to heart disease increased if the infa...y any external factors. "The risk of premature car...cental syndrome, //especially when the fetus is ad... risk factor for cardiovascular disease." Dr...
...e petitioned Hollywood movie executives to add ant...releases which shows stars smoking. According... Joseph Curran initiated the petition after noting...s to also sign their names on a letter he sent to ...
...or’s claim of having produced and purified stem ce... does not have many takers in the British medical ...xperts here have called // on Indian authorities t...d some concern here is Geeta Shroff, who, in the e...
... newly licensed therapists do is no laughing matte...laugh! The first 49 laughing therapists recen...sed to make patients laugh to improve their immune... A doctor herself, Takayanagi has prescribed ...
...Warnings (BBW) issued for high-risk medication by ... medicines to ambulatory care patients. The percen...as nearly 42% according to a survey conducted by H...with noncompliance rates soaring from 0.3 % to 49....
...eek trial by a King County Superior Court jury in ...naecologist was convicted on Wednesday of two coun... against four women who came to his clinics for tr...o counts of rape and two counts of indecent libert...
Other Medicine News:Health News:British Scientists Doubt Delhi Doctor’s Stem Cell Claim 2Health News:Are You Ill? Have A Hard Laugh! 2Health News:Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs 2
(Date:11/25/2009)...itzerland,Nov.25/PRNewswire/-- FromNovember16-18,P...utions,presentedthesecondeditionoftheHearingCarefo...derpopulation.Theconferencebroughttogetherleadinge...than250clinicianswhoworkeverydaywitholderpeoplewit...iscussthelatestresearchandtrendsinhearingcareforol...
(Date:11/25/2009)...v.25/PRNewswire-USNewswire/--RemediumTechnologiesI...opsseverebleeding,wonfirstprizeand$10,000intheMost...allenge2009,companyofficialsannouncetoday. ,, S...medium,steampitchedtheirinventionattheGSCSecurityS..., Remedium( www.remediumtechnologies.com )isdeve...
(Date:11/25/2009)...ewswire/--Reportlinker.comannouncesthatanewmarketr...tedStatesDentalDevicesMarketAnalysisandForecaststo...United-States-Dental-Devices-Market-Analysis-and-F...icesMarketAnalysisandForecaststo2015 ,, Summar...nformationanddatarelatingtotheUSdentaldevicesmarke...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12A Breast Cancer Test That Saves Lives 60601 1A Breast Cancer Test That Saves Lives 60601 2A Breast Cancer Test That Saves Lives 60601 3NBTY to Web Cast Fiscal Fourth Quarter Conference Call 60597 1NBTY to Web Cast Fiscal Fourth Quarter Conference Call 60597 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 1Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 3
...,Genzyme Corporation (Nasdaq: GENZ ) and Bayer Sc... first patient has been treated in the first of tw...efficacy of alemtuzumab for,the treatment of multi...on of Alemtuzumab and Rebif Efficacy in,Multiple S... compare,alemtuzumab to Rebif(R) (interferon beta-...
...ceuticals, Inc. (Nasdaq: ISIS ) announced today t... Inc. (Ibis), has been awarded a subcontract,of a ...n influenza,surveillance research through applicat...H grant, applied for jointly by Ibis and the Lovel...ontracted to Ibis by LRRI,provides funding for res...
Other Medicine Technology:Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 2Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 3Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 4Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 5Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 6Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 2Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 3Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 4Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies 5
...r femur and tibia positioning during nailing, repa...the femur and tibia during intramedullary nailing ...ures. Allows knee to be flexed greater than 90 to ...g fracture. The triangles are available in three h...
Assistant Free Robb Leg Positioner
...-Post and Washer System offers a bioabsorbable PLL... ligament repair or reconstruction. The tapered 35...imum fixation in cortical and cancellous bone. Ide... and the screw cut to length with a Rongeur if nec...
Capello Patient Positoner
Medicine Products: